Drug Information

Drug General Information
Drug ID
D0X4IH
Former ID
DNCL002670
Drug Name
Fluciclatide F-18
Drug Type
Small molecular drug
Indication Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] Phase 2 [549142]
Company
GE Healthcare; National Cancer Institute
Structure
Download
2D MOL

3D MOL
Formula
C74H114FN17O26S3
Canonical SMILES
C1C2C(=O)NC(C(=O)CSCC(NC(C(=O)NC(CSS1)C(=O)NC(C(=O)NCC(<br />=O)NC(C(=O)N2)CCCN=C(N)N)CC(=O)O)CC3=CC=CC=C3)C(=O)NCCO<br />CCOCCOCCNC(=O)COCC(=O)N)CCCCNC(=O)COCC(=O)NCCOCCOCCOCCO<br />CCOCCNC(=O)CON=CC4=CC=C(C=C4)F
InChI
1S/C74H114FN17O26S3/c75-52-13-11-51(12-14-52)39-86-118-45-66(99)82-19-23-110-27-31-114-34-36-115-35-33-113-30-26-109-22-18-81-65(98)44-117-43-63(96)79-15-5-4-9-53-60(93)49-119-46-57(69(103)83-20-24-111-28-32-112-29-25-108-21-17-80-64(97)42-116-41-61(76)94)87-55(37-50-7-2-1-3-8-50)71(105)92-59-48-121-120-47-58(72(106)89-53)91-70(104)54(10-6-16-84-74(77)78)88-62(95)40-85-68(102)56(38-67(100)101)90-73(59)107/h1-3,7-8,11-14,39,53-59,87H,4-6,9-10,15-38,40-49H2,(H2,76,94)(H,79,96)(H,80,97)(H,81,98)(H,82,99)(H,83,103)(H,85,102)(H,88,95)(H,89,106)(H,90,107)(H,91,104)(H,92,105)(H,100,101)(H4,77,78,84)/b86-39+/t53-,54-,55-,56-,57-,58-,59-/m0/s1/i75-1
InChIKey
ILIMGXILWQZPKS-MFVYTYACSA-N
PubChem Compound ID
70697643
PubChem Substance ID
160708738
Target and Pathway
Target(s) Integrin alpha-V/beta-3 Target Info Modulator
References
Ref 549142Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032798)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.